Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-18T00:54:33.913Z Has data issue: false hasContentIssue false

Upholding Tribal Sovereignty in Federal, State, and Local Emergency Vaccine Distribution Plans

Published online by Cambridge University Press:  12 July 2024

Rights & Permissions [Opens in a new window]

Abstract

Cross jurisdictional collaboration efforts and emergency vaccine plans that are consistent with Tribal sovereignty are essential to public health emergency preparedness. The widespread adoption of clearly written federal, state, and local vaccine plans that address fundamental assumptions in vaccine distribution to Tribal nations is imperative for future pandemic response.

Type
Symposium Articles
Creative Commons
This is a work of the US Government and is not subject to copyright protection within the United States. Published by Cambridge University Press on behalf of American Society of Law, Medicine & Ethics. To the extent this work is subject to copyright outside of the United States, such copyright shall be assigned to American Society of Law and licensed to the Publisher. Outside of the United States, the US Government retains a paid-up, non-exclusive, irrevocable worldwide licence to reproduce, prepare derivative works, distribute copies to the public and display publicly the Contribution, and to permit others to do so.
Copyright
© American Society of Law, 2024

Tribal nations have historically been excluded from cross jurisdictional vaccine planning and collaboration critical to the effective distribution of vaccines in emergencies. This exclusion led to severe consequences during the 2009 H1N1 pandemic when a number of Washington Tribes prioritized the vaccination of Tribal elders, departing from Centers for Disease Control and Prevention (CDC) guidance for state and local health departments which, at the time, prioritized children.Reference Schmitz and Erb1 These Tribes based their decision on various factors including cultural considerations and morbidity and mortality rates within their communities.2 At that time, many Tribes in Washington State received delivery of their vaccines from local health jurisdictions (LHJs). In response, some LHJs did not distribute vaccines to these Tribes on the basis that the Tribes’ priority groups for vaccines conflicted with CDC recommendations.3 Several months later, CDC Director Thomas Frieden informed state health officers that all American Indian and Alaska Native people, regardless of age, “should also receive the vaccine on a priority basis.”5 Unfortunately, many Tribes never benefitted from the retroactive guidance, leaving those Tribes without the vaccines needed to protect their citizens.6

H1N1 demonstrated the pressing need to clarify the roles and responsibilities of federal, state, and local governments in emergency vaccine distribution to Tribal nations and the opportunity for each jurisdiction to foster partnerships in disaster response efforts that honor Tribal sovereignty. This article reviews the process for Tribal inclusion in emergency vaccine distribution by (1) providing an overview of Tribal governments’ public health powers; (2) analyzing cross jurisdictional planning efforts in Washington State and the development of the federal COVID-19 Vaccination Program for Tribal nations; and (3) recommending four key components that federal, state, and local officials should incorporate in future emergency vaccine distribution planning to ensure inclusion of Tribal nations.

Tribal Governments’ Public Health Power and Authority

Federal, Tribal, and state governments are the three types of sovereigns in the United States.7 As one of the three sovereigns, federally recognized Tribal governments possess the legal authority to protect the health and welfare of their citizens.8 In contrast to a local government that derives certain powers to enact ordinances from a state constitution or statute, a Tribe’s power is inherent, and the Tribe does not need delegated authority from any source to exercise their public health powers.9 Tribal sovereignty may only be divested or diminished by Congress — not a state or local government or any other party — and no federal law has divested Tribes of their public health powers.10 All Tribal governments possess a wide range of public health powers including, but not limited to: (1) declaring public health emergencies;Reference Sunshine and Hoss11 (2) ordering mandatory isolation and quarantine;12 (3) closing businesses and reservation borders to protect Tribal citizens;13 (4) performing case and contact investigations;14 and (5) conducting surveillance activities.15

Understanding a Tribe’s public health powers in relation to other governments can encourage productive cross jurisdictional efforts. As Professor James Hodge astutely asserts, “Federal, tribal, state and local governments often work together to address public health issues. Yet, sometimes they clash over who is in charge though they clearly have the power to act.”Reference Hodge16 A Tribal government’s “power to act” in the realm of public health is often misunderstood or disregarded despite the fact that a Tribe’s power to govern their people is recognized and protected under federal law.17 H1N1 was a strong reminder that a lack of understanding of Tribal jurisdictional authorities and respect for Tribal sovereignty can have detrimental impacts on Tribal governments and American Indian and Alaska Native people by creating a barrier to critical resources. To effectuate laws and policies that do not further harm Tribal nations, federal, state, and local jurisdictions must support and uphold the sovereign authority of Tribal governments to exercise their public health powers.

Cross Jurisdictional Planning Efforts in Washington State and the Federal COVID-19 Vaccination Program for Tribes

Shortly after the events of H1N1, Tribes and LHJs identified the need for federal and state agencies to provide clear and sufficient guidance regarding the distribution of medical countermeasures (MCM).18 The American Indian Health Commission (AIHC), an organization that works in support of member Tribes and urban Indian health programs in the State of Washington, in partnership with the Washington State Department of Health (WA DOH), engaged Tribes and LHJs to identify and address gaps in the MCM distribution system in Washington State. AIHC facilitated cross jurisdictional collaboration meetings with participants from the twenty-nine federally recognized Tribes in Washington, two urban Indian health programs, the WA DOH, and thirty-five LHJs over a period of several years. Participants engaged in MCM tabletop exercises and developed extensive policy recommendations to WA DOH in 2018.19 Based on these recommendations, AIHC proposed language addressing the distribution of MCM to Tribes to be added to the WA DOH MCM plan. Within months of the impending arrival of the COVID-19 vaccines, WA DOH Secretary John Wiesman, following formal consultation with Washington Tribes, approved the state’s MCM plan which fully adopted AIHC’s proposed cross jurisdictional policy.20

To effectuate laws and policies that do not further harm Tribal nations, federal, state, and local jurisdictions must support and uphold the sovereign authority of Tribal governments to exercise their public health powers.

Subsequently, the AIHC reached out to the CDC’s Public Health Law Program (PHLP) to inquire how CDC could adopt MCM distribution policies similarly deferential to Tribal sovereignty. As the COVID-19 vaccine distribution plans began to form, PHLP connected AIHC with the newly formed Federal Entities Team on CDC’s COVID-19 Vaccine Task Force. The guidance provided by AIHC to the Federal Entities Team helped CDC develop a proposed vaccine distribution program for Tribal nations that became the basis for emergency consultation with Tribes.21 These efforts ultimately resulted in the Tribal COVID-19 vaccine program, the development of the Tribal section of CDC’s COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations,22 and led to vaccine distribution to Tribes through states and the federal Indian Health Service.

With these policies in place prior to the COVID-19 vaccine rollout, federal, state, Tribal, and local jurisdictions had access to improved guidance on the jurisdictional roles and responsibilities for vaccine distribution to Tribes. As reported by Tribes in Washington State in the Tribal Covid-19 Pandemic After Action Report, the “new policy of recognizing the sovereign right of Tribes to receive vaccine and determine their own service and priority populations was the strongest factor for Tribes’ success in conducting widespread vaccination efforts.”23 This policy benefited not only Tribal nations but their surrounding communities, many of whom were able to receive their vaccines from neighboring Tribes.24 In Washington State, Tribes and urban Indian health programs vaccinated over 250,000 individuals.25

Four Key Components for Including Tribes in Federal, State, and Local Emergency Vaccine Distribution Plans

Tribal nations benefit from effective coordination and communication with federal, state, and local governments to review and update vaccine plans. These plans should clearly outline the roles and responsibilities of state and local jurisdictions in distributing and dispensing vaccines to Tribes in accordance with existing federal and state policy. The CDC and Washington State COVID-19 vaccine plans serve as good models by including the following four key components:

  1. 1. Tribal Nations’ Right to Choose Which Jurisdiction to Receive Vaccines From. Each Tribal nation has the sole and sovereign authority to choose among the jurisdiction (e.g., the state where the Tribe is located) or federal agency options for accessing vaccines. State and LHJs do not possess legal authority over how a Tribe receives vaccines.26

  2. 2. Tribal Nations’ Right to Determine Who They Serve. Each Tribal nation has the sole and sovereign authority to determine the populations it chooses to serve in an emergency. For example, Tribes may choose to dispense MCMs they receive to both Tribal members and non-Tribal members living, working, or interacting with the Tribe. State and local jurisdictions do not possess the legal authority to prevent Tribal nations from directly providing vaccines to Tribal and non-Tribal members.27

  3. 3. Tribal Nations’ Right to Establish Vaccine Priority Groups. Each Tribal nation has the sole and sovereign authority to establish their priority groups when there is an FDA approved/authorized vaccine or other accompanying resources for those groups, even if the Tribe’s priority groups differ from what is recommended by federal or state advisory groups such as the Advisory Committee on Immunization Practices (ACIP).28

  4. 4. Coordinating with Tribal Nations. Jurisdictions should regularly engage with Tribal nations within their respective areas for involvement in planning efforts and include Tribal engagement procedures in their vaccination plans.29 CDC’s COVID-19 vaccine playbook underscores the importance of this coordination, stating “[i]t is imperative that state and local jurisdictions, [T]ribal nations, and their planning partners clearly understand each other’s roles and responsibilities in the COVID-19 Vaccination Program.”30 This approach requires communication, flexibility, and trust. Mechanisms to incorporate lessons learned at every level is critical to ensure improvements from H1N1 to COVID-19 vaccine implementation are not lost. Additionally, such mechanisms could be used to find solutions to still existing challenges. Formal documentation of the process; establishing regular meetings between Tribes, state, and LHJs that include reviewing each other’s vaccine plans, capabilities, and resources; creating other forums for developing collaborative relationships; and ensuring Tribal representation when federal agencies develop guidance are some suggested mechanisms that can help save lives and streamline future pandemic response.

Next Steps

In Washington State, the successful distribution of the COVID-19 vaccine to Tribes happened because Tribal Sovereignty and Tribes’ expertise and understanding of the needs of their own population was honored for the first time during an outbreak. Nationally, single dose COVID-19 vaccination coverage is the highest among American Indian and Alaska Native populations.31 Early increases in vaccination coverage demonstrate the success of (1) Tribal nations exercising their public health powers in responding to the COVID-19 pandemic; (2) the adoption of vaccine distribution policies that address the sovereign rights of Tribes; and (3) intensive, collaborative planning between Tribes and local, state, and federal agencies. Moving forward, upholding the legal foundations of Tribal sovereignty requires all jurisdictions to consult and coordinate with Tribes in the development and implementation of future vaccine distribution plans and policies. For states and LHJs with neighboring Tribes, incorporating CDC and WA DOH’s existing policy on emergency vaccine distribution to Tribal nations into their own vaccine plans can serve as a critical component of emergency preparedness and help inform non-emergency events involving the distribution of vaccines and other MCM. The inclusion of Tribal nations in a manner that recognizes and respects Tribal sovereignty is vital for future pandemic response, the health of Tribal communities, and the equitable distribution of critical resources across all federal, Tribal, state, and local jurisdictions.

Acknowledgments

This work was supported by grant funding to the American Indian Health Commission from the State of Washington.

References

Schmitz, L. and Erb, H., American Indian Health Commission, Medical Countermeasures Preparedness Cross-Jurisdictional Collaboration Project (June 30, 2018), at 6, available at <https://aihc-wa.com/wp-content/uploads/2023/06/AIHC-2018-Cross-Jurisdictional-Collaboration-Project-Report.pdf> (last visited November 28, 2023).+(last+visited+November+28,+2023).>Google Scholar
See Letter from T.R. Frieden, CDC Director, to State Health Officers (Dec. 11, 2009), available at <https://www.cdc.gov/h1n1flu/statelocal/frieden_letter_121809.pdf> (last visited November 28, 2023).+(last+visited+November+28,+2023).>Google Scholar
See Schmitz, supra note 1.Google Scholar
Restatement of the Law, The Law of American Indians (Philadelphia: American Law Institute Publishers, 2022) at 1 (citing to S.D. O’Connor, “Lessons from the Third Sovereign: Indian Tribal Courts,” 33 Tulsa Law Journal 1, 1 (1997)).Google Scholar
A.Hoss, “Toward Tribal Health Sovereignty,” Wisconsin Law Review, 2022, no. 2 (2022): 413, 419.Google Scholar
Iron Crow v. Oglala Sioux Tribe, 231 F.2d 89 (8th Cir. 1956); See also Merrion v. Jicarilla Apache Tribe, 455 U.S. 130, 149 (1982).Google Scholar
See Hoss, supra note 8 (citing Santa Clara Pueblo v. Martinez, 436 U.S. 49, 72 (1978)).Google Scholar
Sunshine, G. and Hoss, A., “Emergency Declarations and Tribes: Mechanisms Under Tribal and Federal Law,” Michigan State International Law Review 24, no 1 (2015): 3344.Google ScholarPubMed
Legal Authorities: Isolation and Quarantine (September 17, 2021), Centers for Disease Control and Prevention, available at < https://www.cdc.gov/quarantine/aboutlawsregulationsquarantineisolation.html> (last visited November 28, 2023).+(last+visited+November+28,+2023).>Google Scholar
See Hoss, supra note 8.Google Scholar
Hodge, J.G. Jr., Public Health in a Nutshell (St. Paul, MN: West Academic Publishing, 2018) at 30.Google Scholar
The U.S. Supreme Court has ruled that Tribes possess all attendant rights and powers of governments to protect the health and welfare of their citizens: “The Indian nations had always been considered as distinct, independent, political communities, retaining their original natural rights, as the undisputed possessors of the soil, from time immemorial…” Worcester v. Georgia, 31 U.S. (6 Pet.) 515, 559 (1832); See also, Cherokee Nation v. Georgia, 30 U.S. (5 Pet.) 1 at 16 (1831).Google Scholar
For purposes of this article, medical countermeasures are defined as “medicines and medical supplies that can be used to diagnose, prevent, or treat diseases related to chemical, biological, radiological, or nuclear (CBRN) threats.” Medical Countermeasures (October 5, 2020), Centers for Disease Control and Prevention, available at < https://www.cdc.gov/orr/readiness/mcm2-508.html> (last visited November 28, 2023).+(last+visited+November+28,+2023).>Google Scholar
See Schmitz, supra note 1 at 7–9.Google Scholar
See Letter from John Wiesman, Secretary of Health for Washington State, to Steve Kutz, Chairman for the American Indian Health Commission (Sept. 3, 2020), available at <https://aihc-wa.com/wp-content/uploads/2023/05/Washington-State-Policy-on-Medical-Countermeasures-Distribution-to-Tribes.pdf> (last visited November 28, 2023).+(last+visited+November+28,+2023).>Google Scholar
See Letter from M.D. Weahkee, Assistant Surgeon General, to Tribal Leaders and Urban Indian Organization Leaders (Nov. 18, 2020), available at <https://www.ihs.gov/sites/newsroom/themes/responsive2017/display_objects/documents/2020_Letters/DTLL_DUIOLL_11182020.pdf> (last visited January 11, 2024).+(last+visited+January+11,+2024).>Google Scholar
COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations (October 29, 2020), Centers for Disease Control and Prevention, available at <https://www.cdc.gov/vaccines/imz-managers/downloads/COVID-19-Vaccination-Program-Interim_Playbook.pdf> (last visited November 28, 2023).+(last+visited+November+28,+2023).>Google Scholar
H. Erb and J. McKee, American Indian Health Commission, Tribal Covid-19 Pandemic After Action Report, (March 2023), at v, available at <https://aihc-wa.com/wp-content/uploads/2023/05/Final-AIHC-Tribal-COVID-19-Pandemic-AAR-Report-5-18-23.pdf> (last visited November 28, 2023); National Governor’s Association, Partnering With Tribal Nations For Covid-19 Vaccinations: A Case Study of Alaska, (August 5, 2021), available at <https://www.nga.org/publications/partnering-with-tribal-nations-for-covid-19-vaccinations-a-case-study-of-alaska/> (last visited February 19, 2024)+(last+visited+November+28,+2023);+National+Governor’s+Association,+Partnering+With+Tribal+Nations+For+Covid-19+Vaccinations:+A+Case+Study+of+Alaska,+(August+5,+2021),+available+at++(last+visited+February+19,+2024)>Google Scholar
See Erb, supra note 23, at 14; A. Fields, “Huge Response to Mass COVID-19 Vaccination Site in Sequim is Likely Preview of What’s to Come,” Seattle Times, January 14, 2021, available at <https://www.seattletimes.com/seattle-news/health/huge-response-to-a-mass-covid-19-vaccination-site-in-sequim-is-likely-preview-of-whats-to-come>; H. Furfaro, “Teachers Crying Tears of Gratitude as Washington Tribes Help Speed COVID-19 Vaccines to Them,” Seattle Times, March 18, 2021, available at <https://www.seattletimes.com/education-lab/Tribal-governments-in-washington-help-speed-teacher-vaccination-effort> (last visited February 19, 2024); M. Hellmann, “How a Native American COVID-19 Vaccine Rollout Is a Model for Community-Centered Approaches,” Seattle Times, February 1, 2021, available at <https://www.seattletimes.com/seattle-news/health/we-take-it-for-our-community-how-a-native-american-survey-and-vaccine-rollout-models-a-community-centered-approach> (last visited February 19, 2024).;+H.+Furfaro,+“Teachers+Crying+Tears+of+Gratitude+as+Washington+Tribes+Help+Speed+COVID-19+Vaccines+to+Them,”+Seattle+Times,+March+18,+2021,+available+at++(last+visited+February+19,+2024);+M.+Hellmann,+“How+a+Native+American+COVID-19+Vaccine+Rollout+Is+a+Model+for+Community-Centered+Approaches,”+Seattle+Times,+February+1,+2021,+available+at++(last+visited+February+19,+2024).>Google Scholar
See Erb, supra note 23, at iv.Google Scholar
See Centers for Disease Control and Prevention, supra note 20 at 9; See also Letter from John Wiesman, supra note 20.Google Scholar
See Letter from John Wiesman, supra note 20. Google Scholar
See Centers for Disease Control and Prevention, supra note 22, at 9. Google Scholar
R. Foxworth et al., “Covid-19 Vaccination in American Indians and Alaska Natives-Lessons from Effective Community Responses,” New England Journal of Medicine 385 (2021): 2403–2406. CrossRefGoogle Scholar